临床实践指南:用于吸入物过敏的免疫疗法
Richard K Gurgel1, Fuad M Baroody2, Cecelia C Damask3
1University of Utah, Salt Lake City, Utah, USA.
概括
过敏原免疫疗法 (AIT) 通过诱导耐受性来提供一种管理过敏性鼻炎和喘的方法. 本指南提供基于证据的建议,以确保安全有效的AIT启动和交付,以改善患者护理.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 临床实践指南 临床实践指南
- 免疫治疗是一种免疫疗法.
背景情况:
- 过敏原免疫疗法 (AIT) 是广泛用于过敏性鼻炎 (AR) 和过敏性喘 (AA) 的治疗方法.
- 皮下免疫疗法 (SCIT) 和舌下免疫疗法 (SLIT) 是常见的输送方法.
- 在AIT启动和交付方面存在变化,需要基于证据的建议来提供最佳的患者护理.
研究的目的:
- 确定吸入过敏原免疫疗法 (AIT) 的质量改进机会.
- 为临床医生提供以证据为基础的建议,以AIT管理吸入过敏.
- 为了优化患者护理,促进安全和有效性,减少护理变化,并尽量减少伤害.
主要方法:
- 由指南制定小组 (GDG) 制定临床实践指南 (CPG).
- 专注于基于证据的质量改进机会.
- 基于临床评估,过敏测试和患者因素的建议.
主要成果:
- 强烈建议临床医生在AIT期间诊断和管理过敏反应.
- 建议为不充分控制的AR/AA提供AIT,对SCIT/SLIT进行患者教育,并进行适当的过敏原选择.
- 关于管理局部反应,治疗持续时间和启动AIT的禁忌的指导.
结论:
- 临床医生应为符合条件的AR/AA患者提供AIT.
- 患者教育和对禁忌的仔细评估对于安全有效的AIT至关重要.
- 建议治疗时间至少为3年,以控制症状.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
247
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
247
Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
297
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
297
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524


